Related Experiment Video
Updated: Sep 10, 2025
09:25
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
11.5K
Assessing Compliance and Challenges in Implementing Smoke-Free Zone Regulations in Indonesia
Suhadi Suhadi1, Syefira Salsabila2, Sopar Peranto3
1Department of Health Administration and Policy, Faculty of Public Health, Halu Oleo University, Kendari, Indonesia.
Asian Pacific Journal of Cancer Prevention : APJCP
|August 24, 2025
Summary
Kendari
Area of Science:
- Public Health
- Health Policy Implementation
- Tobacco Control
Background:
- Kendari City Regulation No. 16 of 2014 established smoke-free zones (Perda KTR) across various public facilities.
- Effective implementation is crucial for reducing tobacco-related harm and exposure to secondhand smoke.
Purpose of the Study:
- To evaluate compliance with Kendari's smoke-free zone policy (Perda KTR) in diverse settings.
- To identify the prevalence and distribution of tobacco advertising in Kendari.
Main Methods:
- Qualitative approach with purposive sampling of 200 locations and 11 informants.
- Assessment of "No Smoking" signage, enforcement, cigarette butt presence, designated smoking areas, and tobacco promotions.
- Geospatial mapping of observation sites and tobacco advertising using QGIS.
Main Results:
- Only 7.5% of observed locations fully complied with the smoke-free zone policy.
- Compliance varied significantly by facility type, with healthcare and educational settings showing higher rates.
- Widespread lack of enforcement sanctions (92.5%), presence of cigarette butts (43.5%), and visible tobacco advertisements (14.5%) were noted.
Conclusions:
- The smoke-free zone policy in Kendari is not effectively implemented due to structural, cultural, and economic factors.
- Weak enforcement, limited signage, and insufficient policy dissemination hinder public adherence.
- Strengthened policy enforcement and public awareness campaigns are critical for improving compliance.
More Related Videos
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
11.3K
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
14.4K
Related Concept Videos
01:03Drug Control Governance: Regulatory Bodies and Their Impact
241
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
241
01:17Other Pulmonary Disorders
906
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
906
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:20COPD: Pathogenesis and Clinical Features
517
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
517